David Charlton

Title: Innovations by David Charlton in Antibody Detection

Introduction

David Charlton, an inventive mind located in Redwood City, CA, has made significant strides in the field of assay technology. With his patent focused on the rapid detection and semi-quantitation of anti-adenovirus antibodies, Charlton has contributed to advancements in medical diagnostics.

Latest Patents

Charlton holds one patent titled "Rapid methods and kits for detection and semi-quantitation of anti-adenovirus antibody." His invention discloses methods for efficiently detecting anti-adenovirus antibodies through a device that features a membrane with adsorbed antigens, specifically designed to bind these antibodies. This technology streamlines the detection process by consolidating reactions in a confined area and eliminating manual removal of input reagents, thereby allowing for rapid and convenient assessment.

Career Highlights

Charlton is associated with Cell Genesys, Inc., a company that focuses on innovative approaches to therapy and diagnostics in the fields of gene therapy and immunology. His work demonstrates a commitment to advancing medical technologies that can significantly impact patient care.

Collaborations

During his career, Charlton has collaborated with Daniel R. Henderson, working alongside him to drive innovations in antibody detection methods. Their combined efforts exemplify the collaborative nature of research and development within the biotechnology sector.

Conclusion

David Charlton stands out as a notable inventor in the realm of medical diagnostics, particularly with his contributions to the rapid detection of anti-adenovirus antibodies. His innovations through Cell Genesys, Inc. not only highlight his technical expertise but also reflect the important role of inventors in advancing healthcare technologies.